Innovating Personalized Nephrology Care: Exploring the Potential Utilization of ChatGPT
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The rapid advancement of artificial intelligence (AI) technologies, particularly machine learning, has brought substantial progress to the field of nephrology, enabling significant improvements in the management of kidney diseases. ChatGPT, a revolutionary language model developed by OpenAI, is a versatile AI model designed to engage in meaningful and informative conversations. Its applications in healthcare have been notable, with demonstrated proficiency in various medical knowledge assessments. However, ChatGPT’s performance varies across different medical subfields, posing challenges in nephrology-related queries. At present, comprehensive reviews regarding ChatGPT’s potential applications in nephrology remain lacking despite the surge of interest in its role in various domains. This article seeks to fill this gap by presenting an overview of the integration of ChatGPT in nephrology. It discusses the potential benefits of ChatGPT in nephrology, encompassing dataset management, diagnostics, treatment planning, and patient communication and education, as well as medical research and education. It also explores ethical and legal concerns regarding the utilization of AI in medical practice. The continuous development of AI models like ChatGPT holds promise for the healthcare realm but also underscores the necessity of thorough evaluation and validation before implementing AI in real-world medical scenarios. This review serves as a valuable resource for nephrologists and healthcare professionals interested in fully utilizing the potential of AI in innovating personalized nephrology care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kung, T. H., Cheatham, M., Medenilla, A., Sillos, C., De Leon, L., Elepaño, C., Madriaga, M., Aggabao, R., Diaz-Candido, G., Maningo, J., et al. (2023) · PLOS Digital Health · doi:10.1371/journal.pdig.0000198 · Cited by 4,115 · cited 2×
“%) for the United States Medical Licensing Examination (USMLE) [12,13]. been demonstrated to approach or even exceed the passing threshold (approximately 60”
BackgroundKung, T. H., Cheatham, M., ChatGPT, Medenilla, A., Sillos, C., De Leon, L., Elepaño, C., Madriaga, M., Aggabao, R., Diaz-Candido, G., et al. (2022) · doi:10.1101/2022.12.19.22283643 · Cited by 4,115
Sallam, M. (2023) · Healthcare · doi:10.3390/healthcare11060887 · Cited by 3,126 · cited 5×
“A systematic review indicated that the benefits of ChatGPT were most frequently cited in the context of academic and/or scientific writing, such as efficiency and versatility in writing with text of high quality, improved language, and good readability [10].”
BackgroundInfluentialAn overview of clinical decision support systems: Benefits, risks, and strategies for success
Sutton, R. T., Pincock, D., Baumgart, D. C., Sadowski, D. C., Fedorak, R. N., & Kroeker, K. I. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0221-y · Cited by 3,019
Ayers, J. W., Poliak, A., Dredze, M., Leas, E. C., Zhu, Z., Kelley, J. B., Faix, D. J., Goodman, A. M., Longhurst, C. A., Hogarth, M., et al. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.1838 · Cited by 2,613
Gilson, A., Safranek, C. W., Huang, T., Socrates, V., Chi, L., Taylor, R. A., & Chartash, D. (2023) · JMIR Medical Education · doi:10.2196/45312 · Cited by 2,078
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine
Lee, P., Bubeck, S., & Petro, J. (2023) · New England Journal of Medicine · doi:10.1056/nejmsr2214184 · Cited by 1,738
Privacy in the age of medical big data
Price, W. N., & Cohen, I. G. (2019) · Nature Medicine · doi:10.1038/s41591-018-0272-7 · Cited by 1,522
Dave, T., Athaluri, S. A., & Singh, S. (2023) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2023.1169595 · Cited by 1,204
Eysenbach, G. (2023) · JMIR Medical Education · doi:10.2196/46885 · Cited by 840
Cited by
Kaiser, K. N., Hughes, A. J., Yang, A. D., Turk, A. A., Mohanty, S., Gonzalez, A. A., Patzer, R. E., Bilimoria, K. Y., & Ellis, R. J. (2024) · Journal of Surgical Oncology · doi:10.1002/jso.27821 · Cited by 29
Hu, Y., Liu, J., & Jiang, W. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2555686 · Cited by 14
“LLMs have opened new avenues for enhancing patient care and clinical efficiency [27]. one significant advancement is the development of voice-based conversational ai applications tailored to assisting patients in managing complex treatment regimens. for example, a randomized clinical trial…”
Identification of kidney-related medications using AI from self-captured pill images
Sheikh, M. S., Dreesman, B., Barreto, E. F., Thongprayoon, C., Miao, J., Suppadungsuk, S., Mao, M. A., Qureshi, F., Pham, J. H., Craici, I. M., et al. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2402075 · Cited by 5
Self-citation
Metadata
- Authors
- Miao, J., Thongprayoon, C., Suppadungsuk, S., Garcia Valencia, O. A., Qureshi, F., & Cheungpasitporn, W.
- Venue
- Journal of Personalized Medicine
- Publisher
- MDPI AG
- Published
- 2023-12-04
- Volume
- 13
- Issue
- 12
- Pages
- 1681
- ISSN
- 2075-4426 (ISSN-L)
- OpenAlex
- W4389307562
- Cited by
- 36
- References
- 41
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Innovating Personalized Nephrology Care: Exploring the Potential Utilization of ChatGPT. https://app.cochat.ai/papers/10.3390/jpm13121681
- The paper
- Miao, J., Thongprayoon, C., Suppadungsuk, S., Garcia Valencia, O. A., Qureshi, F., & Cheungpasitporn, W. (2023). Innovating Personalized Nephrology Care: Exploring the Potential Utilization of ChatGPT. Journal of Personalized Medicine. https://doi.org/10.3390/jpm13121681
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.